Abstract:BACKGROUND: The impact of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation on the relationship between plasma homocysteine (Hcy) levels and stroke has been extensively studied and documented in previous study. However, it remains unclear whether the MTHFR C677T mutation can affect the response to Hcy lowering treatment in stroke patients with hyperhomocysteinemia (HHcy). Understanding the impact of genetic factors on treatment response can help optimize personalized treatment strategies for stroke patients with HHcy. We aimed to investigate the potential association between the MTHFR C677T gene polymorphisms and the effectiveness of Hcy lowering treatment using vitamin therapy in stroke patients with HHcy.METHODS: The MTHFR C677T genotype polymorphisms were identified using polymerase chain reaction-restriction fragment length polymorphism, and the distribution of three genotypes in the MTHFR C677T gene locus was compared. The treatment effects of Hcy lowering agents were compared among patients with different genotypes.RESULTS: Among the 320 stroke patients enrolled in the study, 258 (80.6%) were diagnosed with HHcy. Of these, 162 patients (Effective Group) responded well to the clinical Hcy lowering treatment, while 96 patients (Invalid Group) failed to achieve sufficient response even after taking combination supplements of folic acid, Vitamin B6, and methylcobalamin for one month. Significant differences were observed in terms of age (p < 0.001), hypertension (p = 0.034), dyslipidemia (p = 0.022), hyperuricemia (p = 0.013) and genotype distribution of MTHFR C677T gene polymorphism (p < 0.001) between the Invalid group and the Effective group. The multivariate regression analysis revealed that the T allele (odd rations [OR], 1.327; 95% confidence interval [CI], 1.114-1.580; p = 0.0015) was independently associated with an insufficient Hcy lowering treatment effect. Additionally, the TT genotype was independently associated with insufficient response in both the codominant model (OR, 1.645; 95% CI, 1.093-2.476; p = 0.017) and the recessive model (TT versus CC + CT; OR, 1.529; 95% CI, 1.145-2.042; p = 0.004). However, no relationship was observed between CT + TT genotypes and poor treatment effect in the dominate model.CONCLUSIONS: Our findings suggested that the TT genotype and T allele of MTHFR C677T polymorphism were independently associated with an insufficient Hcy lowering treatment effect in stroke patients with HHcy.

Genetic Polymorphisms of Homocysteine Metabolism Related Enzymes in Patients with Coronary Heart Disease

Mthfr C677t Polymorphism And Risk Of Congenital Heart Defects: Evidence From 29 Case-Control And Tdt Studies

Relationship between MTHFR C677T Polymorphisms and Susceptibility of Digestive System Cancer and Coronary Heart Disease

PS042 Risk Factors Associated with Hyperhomocysteinemia Besides Folate in a Chinese Community-Based Population

C677T Genetic Polymorphism of Methylenetetrahydrofolate Reductase in Premature Coronary Heart Disease

Methylenetetrahydrofolate Reductase Polymorphism Associated with Susceptibility to Coronary Heart Disease in Chinese Type 2 Diabetic Patients

MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

The relationship of plasma homocysteine levels and polymorphism in homocysteine metabolism related enzymes with brain stroke

[Study of serum Hcy and polymorphisms of Hcy metabolic enzymes in 192 families affected by congenital heart disease].

Relationship of Plasma Homocysteine and the Gene Polymorphisms of Metabolic Enzymes with Alzheimer's Disease

Methylenetetrahydrofolate Reductase Polymorphism Associates with Susceptibility to Coronary Heart Disease in Chinese Type 2 Diabetic Patients

The Study of Association Between Plasma Homocysteine Level and Coronary Heart Disease

The Study of Plasma Homocysteine Level,the Methylenetetrahydrofolate Reductase (MTHFR) A1298C Polymorphism,the Methionine Synthase (MS) A2756G Polymorphisms and Their Association to Coronary Artery Disease in the Elderly

Associations of Homocysteine Status and Homocysteine Metabolism Enzyme Polymorphisms with Hypertension and Dyslipidemia in a Chinese Hypertensive Population.

Homocysteine and coronary heart disease in Chinese population:a meta-analysis of genetic association studies

Homocysteine concentration in coronary artery disease and severity of coronary lesions

Clinical Study on Effect of Common Methylenetetrahydrofolate Reductase Gene Mutation on Coronary Artery Disease in Hypertension

Methylene tetrahydrofolate reductase gene and coronary artery disease.

Homocysteine Level and N5,10-methylenetetrahydrofolate Reductase Gene Polymorphism in Hypertensive Population

PC82 STUDY ON SERUM HCY LEVEL AND HCY METABOLISM-RELATED ENZYMES POLYMORPHISMS IN NUCLEAR FAMILIES OF PATIENTS WITH CONGENITAL HEART DISEASE

Association between MTHFR C677T Gene Polymorphisms and the Efficacy of Vitamin Therapy in lowering Homocysteine Levels among Stroke Patients with Hyperhomocysteinemia